Homo sapiens (ID 289489) - BioProject

Format

Choose Destination

Accession: PRJNA289489 ID: 289489

Homo sapiens (human)

See Genome Information for Homo sapiens

Navigate Across

The type I JAK inhibitor ruxolitinib is approved for therapy of MPN patients but evokes resistance with longer exposure. More...

Accession	PRJNA289489; GEO: GSE69827
Data Type	Transcriptome or Gene expression
Scope	Multiisolate
Organism	Homo sapiens[Taxonomy ID: 9606] Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
Publications	Meyer SC et al., "CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.", Cancer Cell, 2015 Jul 13;28(1):15-28
Submission	Registration date: 12-Jun-2015 Genomics Core, Memorial Sloan Kettering Cancer Center
Relevance	Medical

Project Data:

Parameter	Value
Data volume, Supplementary Mbytes	3

Parameter	Value
Data volume, Gbases	95
Data volume, Mbytes	74777

Supplemental Content

Homo sapiens
Homo sapiens
Differential expression profiles of type I JAK inhibitor persistent vs. naïve MPN cells

BioProject
Levilactobacillus brevis strain:BSO 310
Levilactobacillus brevis strain:BSO 310
Lactobacillus brevis BSO 310 genome sequencing and assembly

BioProject
Anaplasma phagocytophilum str. HZ
Anaplasma phagocytophilum str. HZ
Obligate intracellular pathogen that causes human granulocytic anaplasmosis

BioProject
Expression and transcript isoform profiling of reprogramming cells expressing a ...
Expression and transcript isoform profiling of reprogramming cells expressing a Sox2 mutant lacking a putative RNA binding motif
Expression and transcript isoform profiling of reprogramming cells expressing a Sox2 mutant lacking a putative RNA binding motif

BioProject
Fungi
Fungi
Fungal 18S Ribosomal RNA (SSU) RefSeq Targeted Loci Project

BioProject

Your browsing activity is empty.

Activity recording is turned off.